
AI-generated summary
In Russia, work is underway to create cancer vaccines and immunotherapeutic drugs as part of national healthcare projects. Previously, the development of the melanoma vaccine “Neoonkovak” and other oncological drugs was announced.
Scientific director of the National Research Center for Epidemiology and Microbiology (NICEM) named after N.F. Gamaleya of the Russian Ministry of Health Alexander Ginzburg said that several types of cancer can be defeated in the near future. His words are quoted by RIA Novosti.
According to Gunzburg, new immune therapy for cancer will make it possible to defeat various types of cancer. It includes personalized vaccines and checkpoint inhibitors.
Earlier, Deputy Prime Minister Tatyana Golikova, within the framework of the national project “New Health Saving Technologies,” announced the registration of ten vital drugs. Among them are drugs for the treatment of various types of cancer, epilepsy, multiple sclerosis and other diseases.
New developments
Ginzburg said that Russia has created a prototype vaccine for the most common cancer - non-small cell lung cancer. It is most often diagnosed in smokers.
The head of the Gamaleya Center said that specialists are now creating cancer vaccines against other types of malignant tumors. All new developments are based on the technology that previously formed the basis of the Neoonkovak melanoma vaccine.
In turn, the head of the FMBA, Veronika Skvortsova, stated that the agency is preparing to release two drugs for the treatment of glioblastoma, one of the most aggressive brain tumors.
Melanoma vaccine
According to Gunzburg, the body of the first patient who received the Russian melanoma vaccine gave a positive immune response. The scientist said that the man feels well and is ready to continue treatment.
The personalized Neooncovac vaccine was administered to a man with skin cancer in April. It was developed at the Gamaleya Research Center for Epidemiology and Microbiology together with the Blokhin National Medical Research Center for Oncology. The drug is produced by the National Medical Research Center of Radiology.
Treatment under compulsory medical insurance
State Duma deputy Alexei Kurinny argued that vaccination could become the main method of treating cancer. He emphasized that immunology is the future.
AI outlook — possibilities, not facts
Ten life-saving drugs will be registered in the near future, including drugs for the treatment of cancer, epilepsy and multiple sclerosis.
Likely · Within months
Vaccination will become the main treatment for cancer in the future.
Possible · Within years

Laboratory-confirmed Ebola cases in the Democratic Republic of the Congo reached 6,041 with 2,911 deaths, according to the Communications and Media Ministry. The outbreak, caused by Bundibugyo ebolavirus, spans six provinces and is the second deadliest in African Ebola surveillance history.

В ЮАР отоларинголог Джон Каллаган отметил 100-й день рождения, продолжая принимать пациентов в Претории. Он заявил, что не собирается уходить на пенсию, так как его разум еще не покинул его, и назвал свою жизнь «в высшей степени удовлетворительной».

Российские ученые идентифицировали ген RAD18 как новый фармакогенетический маркер токсичности химиотерапии при лечении рака желудка, пищевода, поджелудочной железы и колоректального рака. Открытие может помочь в персонализации лечения и снижении осложнений.

Исследование, опубликованное в The Lancet Regional Health — Europe, показало, что начало приема статинов в течение первого года после постановки диагноза сахарного диабета второго типа снижает риск развития деменции на 15 процентов.

Россельхознадзор приостановил обращение серий вакцин «Мультикан-8» и «Мультикан-6» после сообщений о гибели животных. Предварительные данные указывают на возможное нарушение технологии производства.

Исследование STAREE с участием почти 10 тысяч человек старше 70 лет показало, что прием статинов снижает риск первого серьезного сердечно-сосудистого события примерно на 30%.